戻る Agenda
Session 7: Patient Labeling: Global View Part One
Session Chair(s)
Shinobu Uzu, PhD
Senior Executive Director
Pharmaceuticals and Medical Devices Agency (PMDA), Japan
This session provides updates on patient labeling in the EU, Canada, and Asia. EU Patient labeling initiatives will be discussed from the industry point of view, and Health Canada will discuss its ongoing initiative on Plain Language Labeling. In addition, the patient labeling landscape in Asia, including Japan, will be explained.
Speaker(s)
Patient Labeling Initiatives- EU
Megann Looker
Jazz Pharmaceuticals, United Kingdom
Executive Director, Head of Global Labeling
Canada's Patient Medication Information (Part III of the Product Monograph)
Michelle Remillard
Health Canada, Canada
Senior Policy Analyst, Pharmaceutical Drugs Directorate
Patient Labeling in Japan and the Asian Market
Rie Matsui, RPh
Pfizer R&D Japan G.K., Japan
Senior Director, Regional Labeling Head for APAC, International Labeling